chevron-down Created with Sketch Beta.
January 13, 2023

Supreme Court Denies Cert in a Federal Anti-Kickback Case

On January 9, the U.S. Supreme Court denied a Pfizer cert petition without comment.  Pfizer had argued that a Pfizer patient assistance program to cover the high cost-sharing amounts owed by Medicare beneficiaries for treatment with one of Pfizer’s cardiovascular drugs would not violate the federal healthcare anti-kickback act because the Pfizer drug in question held patent protection.

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.